SC 13G

Company

Hepion Pharmaceuticals, Inc.

Filed

October 15, 2015

Accession Number

0001104659-15-070808

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →